White Paper: Analytical Power Tools Open Upstream Bioprocessing Bottlenecks 

The blockbuster success of antibody-based therapeutics for autoimmune diseases, inflammatory diseases and immuno-oncology accelerated the high stakes monoclonal antibody (mAb) development race. Clone selection is a significant upstream bottle-neck slowing bench-to-bedside development progress for new mAb-based therapeutics.

Cy-Clone™ PLUS, a validated assay kit accelerates human mAb production cell-line generation, significantly reducing the time to industrial-scale productivity. The Intellicyt® Cy-Clone PLUS assay combined with the Intellicyt® iQue platform with ForeCyt® Software are the powerful analytical tools that inform rapid go/no-go decisions with multiparameter, high-content data from a single-path workflow.

Learn more about Sartorius solutions for mAb Discovery & Development at www.sartorius.com/mab-oncology.

Complete the form below to download the white paper.

Are you interested in the following cell analysis instruments for your research? 

Other areas of interest? (Please check all that apply)

How can we assist you?